04/22/2021 Grunenthal GmbH (GRUPHA) EUR650m (up from EUR500m) 144A/Reg S green sr sec notes 2-part. B1/B+/BB+ (stable/positive/stable). Via DB (B&D)/GS/BNPP jt glocos and physical books/BBVA/Commerz/ING/RBC/UniCredit joint books. (ESG advisors DB/GS). No reg rights. List ISE. NY law. Settles 05/05 (T+9 US biz days).
- EUR400m (down from EUR500m) due 11/15/26 (5.5y). NC2 (05/15/23) (MWC B+50bp), then at 101.813, 100.906, 100. Equity claw: 2y 40% at 103.625. Reg S ISIN: XS2337064856. Px talk: 3.75%-4.00%. Final price 3.625% at par. Priced 3.625% at 100. +423bp vs DBR 0% 08/15/26.
- EUR250m due 05/15/28 (7y). NC3 (05/15/24) (MWC B+50bp), then at 102.063, 101.031, 100. Equity claw: 3y 40% at 104.125. Reg S ISIN: XS2337703537. Px talk: 4.25%-4.50%. Final price: 4.125% at 100. Priced: 4.125% at 100. +463bp vs DBR 0.50% 02/15/28.
Originally one tranche EUR500m 5.5yNC2. Virtual meetings 04/19-21 (investor call at 10am UKT 04/19). Books closed at 12pm UKT today. Reconfirms were due by 1:45pm UKT today. UOP: repay debt (EUR210m revolver, EUR92.5m term loan A acquisition facilities, EUR150m Schuldschein promissory note), fund the EUR36.5m partial financing of Mestex AG upfront acquisition payment (EUR150m upsize to repay A/B bank loans). Biz: a leading pharmaceutical company focused on pain therapies. HQ: Aachen, Germany.
We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.